Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare…
Supports Development of Ancilia’s Unique Platform that Harnesses CRISPR’s Natural Function to Increase the Utility of Live Bacterial Products for Therapeutic…
- 6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class…
EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg Engineering and continues to make moves in the med-tech space…
Company strengthens sustainability practices prior to commercializationEINDHOVEN, the Netherlands, July 17, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD),…
After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p <…
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change…
Subtle Medical's new software is now available for clinical use in the US, further redefining the speed and quality of…
SenderraCare+ is a game-changer for providers and patients alike. It simplifies the time-consuming process and offers a real-time digital solution…
NEW YORK, July 16, 2024 /PRNewswire/ -- The global industrial laser market size is estimated to grow by USD 2.89…